These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16919735)

  • 1. Research on naltrexone in the criminal justice system.
    Patapis NS; Nordstrom BR
    J Subst Abuse Treat; 2006 Sep; 31(2):113-5. PubMed ID: 16919735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone for probationers and parolees.
    O'Brien C; Cornish JW
    J Subst Abuse Treat; 2006 Sep; 31(2):107-11. PubMed ID: 16919734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Judicially mandated naltrexone use by criminal offenders: a legal analysis.
    Bonnie RJ
    J Subst Abuse Treat; 2006 Sep; 31(2):121-7. PubMed ID: 16919737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding naltrexone for probationers and parolees.
    Stancliff S
    J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
    [No Abstract]   [Full Text] [Related]  

  • 5. Naltrexone as a "mandate" or as a choice comments on "Judicially mandated naltrexone use by criminal offenders: a legal analysis".
    Presenza LJ
    J Subst Abuse Treat; 2006 Sep; 31(2):129-30. PubMed ID: 16919738
    [No Abstract]   [Full Text] [Related]  

  • 6. Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.
    Lee JD; Friedmann PD; Boney TY; Hoskinson RA; McDonald R; Gordon M; Fishman M; Chen DT; Bonnie RJ; Kinlock TW; Nunes EV; Cornish JW; O'Brien CP
    Contemp Clin Trials; 2015 Mar; 41():110-7. PubMed ID: 25602580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
    Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot naltrexone in lieu of incarceration: a behavioral analysis of coerced treatment for addicted offenders.
    Marlowe DB
    J Subst Abuse Treat; 2006 Sep; 31(2):131-9. PubMed ID: 16919739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narcotic antagonists: naltrexone progress report: foreword.
    Jaffe J
    NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
    [No Abstract]   [Full Text] [Related]  

  • 10. Naltrexone for opioid dependence. An additional tool for general practitioners.
    Tedeschi M
    Aust Fam Physician; 2002 Jan; 31(1):18-20. PubMed ID: 11840882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual.
    Soares WE; Wilson D; Gordon MS; Lee JD; Nunes EV; O'Brien CP; Shroff M; Friedmann PD
    Drug Alcohol Depend; 2019 Jan; 194():482-486. PubMed ID: 30522048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoi MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2004 Jun; 26(4):285-94. PubMed ID: 15182893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone pharmacotherapy for opioid dependent federal probationers.
    Cornish JW; Metzger D; Woody GE; Wilson D; McLellan AT; Vandergrift B; O'Brien CP
    J Subst Abuse Treat; 1997; 14(6):529-34. PubMed ID: 9437624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone implants as treatment for heroin dependence: part I.
    Byrne A; Graham G; Hallinan R; Murnion B
    Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
    [No Abstract]   [Full Text] [Related]  

  • 15. What you need to know: addiction--prescribing naltrexone.
    Yeo BK
    Singapore Med J; 1997 Feb; 38(2):92-3. PubMed ID: 9269372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity.
    Ali R; Thomas P; White J; McGregor C; Danz C; Gowing L; Stegink A; Athanasos P
    Drug Alcohol Rev; 2003 Dec; 22(4):425-31. PubMed ID: 14660132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does naltrexone affect craving in abstinent opioid-dependent patients?
    Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
    Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdoses.
    Arnold-Reed DE; Hulse GK; Hansson RC; Murray SD; O'Neil G; Basso MR; Holman CD
    Addict Biol; 2003 Sep; 8(3):343-50. PubMed ID: 13129837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
    Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication-assisted treatment research with criminal justice populations: challenges of implementation.
    Gordon MS; Kinlock TW; Miller PM
    Behav Sci Law; 2011; 29(6):829-45. PubMed ID: 22086665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.